Cancer Detection and Diagnosis Research in Illinois
Cancer Detection and Diagnosis Research (93.394) awarded $77.7 million to recipients in Illinois in 65 grants from fiscal 2021 to 2025, 2.9% of the program's national total. Northwestern University received the most, $24.0 million.
- Awarded in Illinois$77.7 million
- Awards65
- Share of the program2.9%
- Rank among states10th of 45
- National total$2.7 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 28 | $12.8 million |
| FY 2022 | 35 | $17.7 million |
| FY 2023 | 35 | $15.4 million |
| FY 2024 | 35 | $15.0 million |
| FY 2025 | 33 | $16.7 million |
Recipients in Illinois
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Northwestern University | Colleges and universities | 18 | $24.0 million |
| University of Illinois | Colleges and universities | 13 | $15.3 million |
| The University of Chicago | Colleges and universities | 13 | $14.0 million |
| University of Illinois | Colleges and universities | 8 | $8.3 million |
| Northwestern University | Colleges and universities | 2 | $3.1 million |
| Endeavor Health Clinical Operations | Nonprofits | 2 | $2.3 million |
| Clarix Imaging Corp | Small businesses | 1 | $2.2 million |
| Qmis LLC | Small businesses | 1 | $2.0 million |
| Acoustic Range Estimates, LLC | Small businesses | 1 | $2.0 million |
| O2M Technologies LLC | Small businesses | 3 | $2.0 million |
Open opportunities under this program
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
- Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)
- Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
See all 47 on the program page
Questions people ask
How much Cancer Detection and Diagnosis Research money goes to Illinois?
$77.7 million from fiscal 2021 to 2025, across 65 awards. Illinois ranks 10th of 45 states and territories for this program.
Who receives Cancer Detection and Diagnosis Research money in Illinois?
The largest recipient is Northwestern University, with $24.0 million in 18 awards. Next are University of Illinois and The University of Chicago.
Can organizations in Illinois apply now?
Yes, 47 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Detection and Diagnosis Research in other states
Other large programs in Illinois
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- Federal Transit Formula Grants
- National School Lunch Program
- Title I Grants to Local Educational Agencies
- Special Education Grants to States
- Temporary Assistance for Needy Families
- Children's Health Insurance Program
- Child Care and Development Block Grant